JACOBS LEVY EQUITY MANAGEMENT, INC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$3,463,994
+51.9%
209,939
-41.8%
0.02%
+61.5%
Q2 2023$2,280,629
+60.6%
360,859
-13.7%
0.01%
+44.4%
Q1 2023$1,419,955
-40.9%
418,249
+0.7%
0.01%
-43.8%
Q4 2022$2,400,637
+288.5%
415,335
+9496.5%
0.02%
+220.0%
Q4 2020$618,0004,3280.01%
Other shareholders
CARDLYTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders